London Daily

Focus on the big picture.
Monday, Mar 30, 2026

World Health Organisation warns countries not to treat Covid-19 patients with unproven medicine amid scramble for a cure

History of medicine abounds with ‘examples of drugs that worked on paper or in a test tube but were actually harmful’, WHO chief says. Warning comes as cases of the respiratory ailment caused by the coronavirus surge worldwide

The World Health Organisation (WHO) on Friday warned governments against treating infected coronavirus patients with medications not scientifically proven to fight the pathogen.

WHO Director General Tedros Adhanom Ghebreyesus issued the warning as cases of Covid-19, the respiratory ailment caused by the coronavirus that emerged in China late last year, surged worldwide, prompting health authorities to scramble to find treatments.

“We call on all individuals and countries to refrain from using therapeutics that have not been demonstrated to be effective in the treatment of Covid-19,” Tedros said. “The history of medicine is strewn with examples of drugs that worked on paper, or in a test tube, but didn't work in humans, or were actually harmful.”

“During the most recent Ebola epidemic, for example, some medicines that were thought to be effective were found not to be as effective as other medicines, when they were compared during a clinical trial,” he said. “We must follow the evidence. There are no short cuts.”

Tedros did not name any individuals, including US President Donald Trump, who came under criticism for touting chloroquine – a medicine for malaria – as a treatment for Covid-19 patients.

Trump defended his aim to start using the medicine regardless of the WHO warning.

Asked in a White House briefing about whether he would continue pushing chloroquine as a treatment, Trump said: “We have people dying now.”

“If we're going to go into labs and test all of this for a long time, we can test it on people right now who are in serious trouble who would dying,” Trump said. “If it works, we've done a great thing. If it doesn't work, you know, we tried.”

The US leader began pushing for chloroquine as a treatment last week.

In a press briefing on March 19, Trump, referring to the medication, said: “Normally the [US Food and Drug Administration] would take a long time to approve something like that, and it was approved very, very quickly and it's now approved, by prescription.”

Soon after Trump’s comments, the FDA said that chloroquine had not been approved for treating Covid-19 and that more tests were needed to determine its safety and effectiveness.

A day later, US infectious disease expert Dr. Anthony Fauci said evidence that chloroquine worked against Sars-CoV-2, the scientific name for the new coronavirus, was “anecdotal”.

The effort to prove the medication’s efficacy against the contagion, he said, “was not done in a controlled clinical trial, so you really can’t make any definitive statement about it”.

Many US media outlets have reported shortages of chloroquine and hydroxychloroquine, a newer derivative of chloroquine that is also used for malaria, since Covid-19 cases began to surge in the country.

Tedros also warned that “off-label” usage of medication – the prescribing of sanctioned drugs for other, unapproved purposes – to treat Covid-19 potentially threatens the health of many individuals not infected with the new illness.

“We need to ensure that using unproven drugs does not create a shortage of those medicines to treat diseases for which they have proven effective,” the head of the UN agency said in the briefing.

Newsletter

Related Articles

0:00
0:00
Close
Starmer Signals UK Crackdown on Addictive Social Media Features
Rising Costs Push One in Five UK Hospitality Businesses to the Brink of Closure
Man Arrested on Suspicion of Attempted Murder After Car Strikes Pedestrians in UK, Injuring Seven
Escalating Conflict Involving Iran Tightens Fiscal Pressures and Highlights UK Economic Vulnerabilities
UK Moves to Confront Russian ‘Shadow Fleet’ Operating in Its Waters
UK Housing Divide Deepens as Older Owners Hold Wealth While Under-30s Face Mounting Barriers
London Demonstration Calls on UK to Recognize Iranian Opposition’s Provisional Government
UK Green Party Vote on ‘Zionism is Racism’ Motion Collapses Amid Internal Disputes and Technical Failures
SNL UK Ignites Debate with Sharp Royal Satire Targeting Prince Andrew and Prince William
EU Proposes ‘Emergency Brake’ to Resolve Deadlock in UK Youth Mobility Talks
Thousands Rally in London to Oppose Rise of Far-Right Movements
Hong Kong Official Rejects Allegations of Surveillance Orders Targeting UK-Based Dissidents
PayPal Expands Cryptocurrency Services to Allow UK Users to Buy and Sell Bitcoin
UK Minister Challenges Reform Party’s ‘Pro-Family’ Agenda as Debate Intensifies
Concerns Grow Over Meningitis Risk Among UK Students Amid Warning Signs of New Outbreaks
Japanese Grand Prix 2026: Schedule, UK Start Times and Full Broadcast Details
Electric Vehicles Seen as Strategic Solution to UK Fuel Reserve Concerns
Rise of Lone-Actor Threats and Online Radicalisation Drives New Wave of Antisemitic Attacks in the UK
Canada Advances Plan to Ban Cryptocurrency Donations in Election Campaigns
UK Faces Looming Medicine Shortages as Iran Conflict Threatens Supply Chains
Deadly Meningitis Outbreak in the U.K. Highlights Urgent Need for Vaccination
Fresh Claims Emerge Over Harry and Meghan’s Australia Visit as Insider Speaks Out
NATO Assessment Indicates UK Defence Spending Has Fallen Below Alliance Average
FTSE 100 Slips as Middle East Tensions Weigh on Investor Sentiment
UK Economy Begins to Feel Early Impact of Iran Conflict as Policy Challenges Intensify
Russian National Jailed in UK After Assault Case Linked to Barron Trump’s Alert
Energy Price Surge Accelerates Shift Away from Fossil Fuels in UK Homes
UK Museums House More Than 260,000 Human Remains, New Report Reveals
Surging UK Gilt Yields Reflect Inflation Pressures and Fiscal Uncertainty
UK Issues Updated Guidance on Children’s Screen Time with Focus on Balance and Wellbeing
UK Migration Figures Show Shifting Trends Across Asylum, Visas and Channel Crossings
UK Watchdog Launches Probe into Five Firms Over Alleged Fake Reviews and Ratings
Jaguar Land Rover Halts Production at UK Plant Amid Supplier Disruption
UK Police Reverse Position, Confirm Arrests Will Resume for Palestine Action Protests
UK Small Businesses Face Europe’s Steepest Cost Pressures, New Survey Reveals
US Envoy Urges UK to Proceed with King’s Visit Amid Diplomatic Sensitivities
FTSE 100 Drops Over One Percent as Middle East Tensions Weigh on Markets
UK CO2 Plant Set to Reopen as Authorities Move to Safeguard Supplies Amid Middle East Tensions
Trump Urges Stronger Defence Investment as He Questions Allied Naval Capabilities
New COVID Variant Detected in UK Raises Concerns Over Vaccine Effectiveness
FTSE Russell Moves to Standardise Free-Float Rules for UK and International Listings
HBO Max Launches in UK and Ireland, Marking Major Step in Global Streaming Expansion
UK Signals Readiness to Seize Russian ‘Shadow Fleet’ Vessels in Escalation of Sanctions Enforcement
Escalating Middle East Conflict Seen as Major Threat to UK Economic Stability
Early Challenges Mark Prince Harry and Meghan’s Australia Visit
UK Government Rejects Cover-Up Claims After Theft of Former PM Aide’s Phone
Cyprus Opens Strategic Talks with UK Over Sovereign Base Areas
UK Faces Risk of Sharp Inflation Surge Despite Stable Pre-Crisis Figures
UK Police Arrest Two Over Suspected Antisemitic Arson as Iran Link Investigated
UK Inflation Holds at Three Percent Ahead of Oil Price Shock from Iran Conflict
×